2nd Immuno-Oncological Meeting of the Israel Immunological Society (2022) February 22-24, 2022| Haifa, Israel
Biond Biologics presented a poster at the Israel Immunological Meeting that took place in Haifa, Israel, February 22-24, 2022.
The poster title was “CD28 shedding is a novel immune-regulatory mechanism associated with anti-PD-1 resistance”.
Biond reported the discovery of a novel regulatory mechanism which blocks the CD28/B7 activation pathway and presented data about the development of therapeutic drug candidate for the inhibition of this regulatory mechanism (BND-67).